Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate

The subregional distribution of mu opioid receptors and corresponding G‐protein activation were examined in the striatum, amygdala, and extended amygdala of cynomolgus monkeys. The topography of mu binding sites was defined using autoradiography with [3H]DAMGO, a selective mu ligand. In adjacent sections, the distribution of receptor‐activated G proteins was identified with DAMGO‐stimulated guanylyl 5′(γ‐[35S]thio)triphosphate ([35S]GTPγS) binding. Within the striatum, the distribution of [3H]DAMGO binding sites was characterized by a distinct dorsal–ventral gradient with a higher concentration of binding sites at more rostral levels of the striatum. [3H]DAMGO binding was further distinguished by the presence of patch‐like aggregations within the caudate, as well as smaller areas of very dense receptor binding sites, previously identified in human striatum as neurochemically unique domains of the accumbens and putamen (NUDAPs). The amygdala contained the highest concentration of [3H]DAMGO binding sites measured in this study, with the densest levels of binding noted within the basal, accessory basal, paralaminar, and medial nuclei. In the striatum and amygdala, the distribution of DAMGO‐stimulated G‐protein activation largely corresponded with the distribution of mu binding sites. The central and medial nuclei of the amygdala, however, were notable exceptions. Whereas the concentration of [3H]DAMGO binding sites in the central nucleus of the amygdala was very low, the concentration of DAMGO‐stimulated G‐protein activation in this nucleus, as measured with [35S]GTPγS binding, was relatively high compared to other portions of the amygdala containing much higher concentrations of [3H]DAMGO binding sites. The converse was true in the medial nucleus, where high concentrations of binding sites were associated with lower levels of DAMGO‐stimulated G‐protein activation. Finally, [3H]DAMGO and [35S]GTPγS binding within the amygdala, particularly the medial nucleus, formed a continuum with the substantia innominata and bed nucleus of the stria terminalis, supporting the concept of the extended amygdala in primates. J. Comp. Neurol. 433:471–485, 2001. © 2001 Wiley‐Liss, Inc.

[1]  R P Lesser,et al.  Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. , 1997, Annals of neurology.

[2]  B. Gosnell Involvement of μ opioid receptors in the amygdala in the control of feeding , 1988, Neuropharmacology.

[3]  C. W. Scott,et al.  Reconstitution of catecholamine-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to the stimulatory GTP-binding protein of adenylate cyclase. , 1984, Biochemistry.

[4]  K. Jakobs,et al.  Muscarinic acetylcholine receptor-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. , 1989, European journal of biochemistry.

[5]  R. Lesser,et al.  Imaging of δ‐ and μ‐opioid receptors in temporal lobe epilepsy by positron emission tomography , 1997 .

[6]  S. Snyder,et al.  Regional Distribution of Opiate Receptor Binding in Monkey and Human Brain , 1973, Nature.

[7]  M. E. Lewis,et al.  Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.

[8]  G. Alheid Amygdala and extended amygdala , 1995 .

[9]  J. Joyce,et al.  Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Graybiel Neuropeptides in the basal ganglia. , 1986, Research publications - Association for Research in Nervous and Mental Disease.

[11]  L. Heimer,et al.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata , 1988, Neuroscience.

[12]  H. Groenewegen,et al.  Evidence for a multi‐compartmental histochemical organization of the nucleus accumbens in the rat , 1993, The Journal of comparative neurology.

[13]  L. Heimer Basal forebrain in the context of schizophrenia , 2000, Brain Research Reviews.

[14]  D. Amaral,et al.  An autoradiographic study of the projections of the central nucleus of the monkey amygdala , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  H. Stephan,et al.  Septum Development in Primates , 1976 .

[16]  S. Gauthier,et al.  Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain , 1987, Brain Research Bulletin.

[17]  G. Koob The Role of the Striatopallidal and Extended Amygdala Systems in Drug Addiction , 1999, Annals of the New York Academy of Sciences.

[18]  A. Graybiel,et al.  [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: Delineation of striosomal compartments and pallidal and nigral subdivisions , 1988, Neuroscience.

[19]  H. Kosterlitz,et al.  EFFECTS OF CHANGES IN THE STRUCTURE OF ENKEPHALINS AND OF NARCOTIC ANALGESIC DRUGS ON THEIR INTERACTIONS WITH μ‐ AND δ‐RECEPTORS , 1980 .

[20]  G. Koob,et al.  Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal , 1990, Neuroscience.

[21]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[22]  G. Aston-Jones,et al.  The Bed Nucleus of the Stria Terminalis: A Target Site for Noradrenergic Actions in Opiate Withdrawal , 1999, Annals of the New York Academy of Sciences.

[23]  M. Zarbin,et al.  Distribution of opiate receptors in the monkey brain: An autoradiographic study , 1982, Neuroscience.

[24]  H. N. Wagner,et al.  Multicompartmental Analysis of [11C]-Carfentanil Binding to Opiate Receptors in Humans Measured by Positron Emission Tomography , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  D. Selley,et al.  Effects of chronic morphine administration on mu opioid receptor- stimulated [35S]GTPgammaS autoradiography in rat brain , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  P. Kalivas,et al.  Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. , 1983, The Journal of pharmacology and experimental therapeutics.

[27]  C. Gerfen,et al.  Cocaine self-administration differentially alters mRNA expression of striatal peptides. , 1992, Brain research. Molecular brain research.

[28]  Alan J. Cross,et al.  Subtraction autoradiography of opiate receptor subtypes in human brain , 1987, Brain Research.

[29]  G. Aghajanian,et al.  Pertussis toxin blocks the outward currents evoked by opiate and α2-agonists in locus coeruleus neurons , 1986, Brain Research.

[30]  J. Palacios,et al.  Multiple opiate receptor in human brain: an autoradiographic investigation. , 1983, Life sciences.

[31]  J. Daunais,et al.  Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat , 1997, Brain Research.

[32]  D. Price,et al.  The bed nucleus‐amygdala continuum in human and monkey , 1991, The Journal of comparative neurology.

[33]  S. Snyder,et al.  Opiate receptor binding in rhesus monkey brain: association with limbic structures , 1978, Brain Research.

[34]  J. Palacios,et al.  High resolution separation methods for the determination of intact human erythropoiesis stimulating agents. A review. , 2012, Analytica chimica acta.

[35]  G. Bell,et al.  Molecular biology of opioid receptors , 1993, Trends in Neurosciences.

[36]  T. Katada,et al.  Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells. , 1983, The Journal of biological chemistry.

[37]  M. Kreek,et al.  Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. , 1994, Neuroreport.

[38]  D. Selley,et al.  Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions. , 2000, Biochemical pharmacology.

[39]  G. Biggio,et al.  Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone. , 1978, Science.

[40]  M. Herkenham,et al.  Molecular alterations in the neostriatum of human cocaine addicts , 1993, Synapse.

[41]  D. Amaral,et al.  Organization of the intrinsic connections of the monkey amygdaloid complex: Projections originating in the lateral nucleus , 1998, The Journal of comparative neurology.

[42]  U. Schwabe,et al.  Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding. , 1993, Molecular pharmacology.

[43]  L. Heimer,et al.  Substantia innominata: a notion which impedes clinical–anatomical correlations in neuropsychiatric disorders , 1997, Neuroscience.

[44]  R. Pearson,et al.  The Human Nervous System. Basic Elements of Structure and Function , 1967, The Yale Journal of Biology and Medicine.

[45]  S. Haber,et al.  The primate substantia nigra and VTA: integrative circuitry and function. , 1997, Critical reviews in neurobiology.

[46]  M. Herkenham,et al.  Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum , 1981, Nature.

[47]  B. Berger,et al.  Chemoanatomic compartments in the human bed nucleus of the stria terminalis , 1989, Neuroscience.

[48]  Alan A. Wilson,et al.  Quantification of mu and non–mu opiate receptors in temporal lobe epilepsy using positron emission tomography , 1991, Annals of neurology.

[49]  Nikolaus R. McFarland,et al.  The Concept of the Ventral Striatum in Nonhuman Primates , 1999, Annals of the New York Academy of Sciences.

[50]  Á. Pazos,et al.  Autoradiography of receptor-activated G-proteins in post mortem human brain , 2000, Neuroscience.

[51]  S. Watson,et al.  Anatomical Distribution of Opioid Receptors in Mammalians: An Overview , 1993 .

[52]  Alterations in opiate receptor binding in MPTP-induced hemiparkinsonian monkeys , 1991, Neuroscience Letters.

[53]  J. Zubieta,et al.  Brain opioid receptor measurements by positron emission tomography in normal cycling women: relationship to luteinizing hormone pulsatility and gonadal steroid hormones. , 1998, The Journal of clinical endocrinology and metabolism.

[54]  H. Berendse,et al.  Evidence For Two Neurochemical Divisions in the Human Nucleus Accumbens , 1994, The European journal of neuroscience.

[55]  R. Ehrman,et al.  Opiate receptors, neuropeptides in CNS and CSF of two Macaca species with different responsiveness to opiates. , 1986, European journal of pharmacology.

[56]  C. Breivogel,et al.  Regional differences in cannabinoid receptor/G-protein coupling in rat brain. , 1997, The Journal of pharmacology and experimental therapeutics.

[57]  E. Lynd-Balta,et al.  The orbital and medial prefrontal circuit through the primate basal ganglia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  A. Herz,et al.  Opiate receptor binding sites in human brain , 1982, Brain Research.

[59]  D. Selley,et al.  Differences in G-protein activation by μ-and δ-opioid, and cannabinoid, receptors in rat striatum , 1996 .

[60]  J. Johnston Further contributions to the study of the evolution of the forebrain , 1923 .

[61]  D. Amaral,et al.  The amygdalostriatal projections in the monkey. An anterograde tracing study , 1985, Brain Research.

[62]  J. Daunais,et al.  Mu and kappa1 opioid-stimulated [35S]guanylyl-5′-o-(γ-thio)-triphosphate binding in cynomolgus monkey brain , 1999, Neuroscience.

[63]  G. Di Chiara,et al.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[64]  D. Selley,et al.  In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Daunais,et al.  Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. , 1993, Neuroreport.

[66]  L. Heimer,et al.  Piecing together the puzzle of basal forebrain anatomy. , 1991, Advances in experimental medicine and biology.

[67]  D. Selley,et al.  Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum. , 1996, European journal of pharmacology.

[68]  T. Kaneko,et al.  Immunohistochemical localization of μ‐opioid receptors in the central nervous system of the rat , 1996, The Journal of comparative neurology.

[69]  S. Haber,et al.  The distribution of enkephalin immunoreactive fibers and terminals in the monkey central nervous system: An immunohistochemical study , 1982, Neuroscience.

[70]  M. E. Lewis,et al.  Anatomical relationship between opioid peptides and receptors in rhesus monkey brain , 1984, Brain Research Bulletin.

[71]  L. Sokoloff,et al.  Comparative Effects of Acute and Chronic Administration of Amphetamine on Local Cerebral Glucose Utilization in the Conscious Rat , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[72]  A. Parent,et al.  The subcortical afferents to caudate nucleus and putamen in primate: A fluorescence retrograde double labeling study , 1983, Neuroscience.

[73]  Robert F. Dannals,et al.  Increased mu opioid receptor binding detected by PET in cocaine–dependent men is associated with cocaine craving , 1996, Nature Medicine.

[74]  L. Goldstein The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction , 1992, The Yale Journal of Biology and Medicine.

[75]  Michael Davis,et al.  The Extended Amygdala: Are the Central Nucleus of the Amygdala and the Bed Nucleus of the Stria Terminalis Differentially Involved in Fear versus Anxiety? , 1999, Annals of the New York Academy of Sciences.

[76]  H. Akil,et al.  Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain , 1987 .

[77]  G. Meyer,et al.  Aggregations of granule cells in the basal forebrain (islands of Calleja): Golgi and cytoarchitectonic study in different mammals, including man , 1989, The Journal of comparative neurology.

[78]  J. Zubieta,et al.  Gender and age influences on human brain mu-opioid receptor binding measured by PET. , 1999, The American journal of psychiatry.

[79]  C. W. Ragsdale,et al.  Fibers from the basolateral nucleus of the amygdala selectively innervate striosomes in the caudate nucleus of the cat , 1988, The Journal of comparative neurology.

[80]  H. Berendse,et al.  Densitometrical analysis of opioid receptor ligand binding in the human striatum—I. Distribution of μ opioid receptor defines shell and core of the ventral striatum , 1996, Neuroscience.